BMO Capital Maintains Outperform on Constellium, Lowers Price Target to $24
Portfolio Pulse from Benzinga Newsdesk
BMO Capital analyst Katja Jancic maintains an Outperform rating on Constellium (NYSE:CSTM) but lowers the price target from $25 to $24.
July 24, 2024 | 4:01 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
BMO Capital's analyst Katja Jancic maintains an Outperform rating on Constellium but lowers the price target from $25 to $24.
The Outperform rating suggests a positive outlook, but the lowered price target indicates some caution. This mixed signal is likely to result in a neutral short-term impact on the stock price.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100